Shares of Cardio Diagnostics Holdings, Inc. (CDIO), an artificial intelligence-powered precision cardiovascular medicine company, are rising nearly 150% Tuesday morning following the launch of PrecisionCHD, a blood test for the early detection of coronary heart disease.
PrecisionCHD, a non-invasive test detects coronary heart disease with better than 75% sensitivity in both men and women. the company said.
CDIO is at $3.15 currently. It has traded in the range of $0.79-$10.25 in the last 1 year.
Source: Read Full Article
Lates News:
-
Cryptos Rise, XRP Now Ranked 4th Overall
-
$BTC Market Cap Dominance Falls to Levels Last Since in January 2018
-
Bitcoin ($BTC) Price Hitting $1 Million Easier Than Expected If US Approves Spot ETF, Analyst Reveals
-
Arco Platform Rises 14% On Sweetened Buyout Proposal
-
Bitcoin's Surging Transaction Fees Viewed As “Direct Attack” By A Cross-Section Of The Community